| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| septembre 2005 - 93 Spécialités |
|
| | | IPro | IPat | | Cefuroxim Sandoz 500mg | 14 | 15.00 | 32.75 | 10% | | Comprimés filmés: Cefuroximum 500 mg | Sandoz
Pharmaceuticals AG | A / LS / SG | FB | | G |  |
| | | IPro | IPat | | Cefuroxim Sandoz 250mg - C | 14 | DDP | DDP | N.O. | | Comprimés filmés: Cefuroximum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IPro | IPat | | Cefuroxim Sandoz 250mg - C | 10 x 14 | DDP | DDP | N.O. | | Comprimés filmés: Cefuroximum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IPro | IPat | | Cefuroxim Sandoz 500mg | 10 x 14 | DDP | DDP | N.O. | | Comprimés filmés: Cefuroximum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | seringue(s) | 12.93 | 30.50 | 10% | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | seringue(s) | 15.11 | 32.85 | 10% | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | seringue(s) | 17.69 | 35.60 | 10% | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | seringue(s) | 20.40 | 38.50 | 10% | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | seringue(s) | 22.85 | 41.20 | 10% | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | seringue(s) | 26.51 | 45.15 | 10% | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | seringue(s) | 16.84 | 34.65 | 10% | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | seringue(s) | 19.36 | 37.40 | 10% | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | seringue(s) | 21.97 | 40.20 | 10% | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A / LS / SO | FB | | G | |
| | | IPro | | | Eloxatine 50 mg/10 ml | Flacon perforable | 84.32 | 107.65 | 10% | | Concentré pour perfusion: Oxaliplatinum 50mg / 10ml | Sanofi-Aventis
(Suisse) SA | A / LS / SO | FB | | G | |
| | | IPro | | | Eloxatine 100 mg/20 ml | Flacon perforable | 168.03 | 198.20 | 10% | | Concentré pour perfusion: Oxaliplatinum 100mg / 20ml | Sanofi-Aventis
(Suisse) SA | A / LS / SO | FB | | G | |
| | | IPro | | | Eloxatine 200 mg/40 ml | Flacon perforable | 289.02 | 329.15 | 10% | | Concentré pour perfusion: Oxaliplatinum 200mg / 40ml | Sanofi-Aventis
(Suisse) SA | A / LS / SO | FB | | G | |
| | | IPro | IPat | | Meto Zerok 25 - C | 30 Comprimé(s) | 2.28 | 11.70 | 10% | | Comprimés retards: Metoprololi Tartras 25 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 25 - C | 100 Comprimé(s) | 6.60 | 16.40 | 10% | | Comprimés retards: Metoprololi Tartras 25 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 50 - C | 30 Comprimé(s) | 3.73 | 13.30 | 10% | | Comprimés retards: Metoprololi Tartras 50 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 50 - C | 100 Comprimé(s) | 10.55 | 27.90 | 10% | | Comprimés retards: Metoprololi Tartras 50 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 100 - C | 30 Comprimé(s) | 6.10 | 15.85 | 10% | | Comprimés retards: Metoprololi Tartras 100 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 100 - C | 100 Comprimé(s) | 17.30 | 35.20 | 10% | | Comprimés retards: Metoprololi Tartras 100 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 200 | 30 Comprimé(s) | 7.48 | 17.35 | 10% | | Comprimés retards: Metoprololi Tartras 200 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Meto Zerok 200 | 100 Comprimé(s) | 21.48 | 39.75 | 10% | | Comprimés retards: Metoprololi Tartras 200 mg | Sandoz
Pharmaceuticals AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Fluoxetin-Mepha
Dispersible 20 mg | 10 Comprimé(s) | 3.21 | 12.80 | 10% | | Comprimés dispersibles: Fluoxetinum 20 mg | Mepha Pharma AG | ● B / LS / SG | FB | | G | |
| | | IPro | IPat | | Fluoxetin-Mepha
Dispersible 20 mg | 30 Comprimé(s) | 9.66 | 26.90 | 10% | | Comprimés dispersibles: Fluoxetinum 20 mg | Mepha Pharma AG | ● B / LS / SG | FB | | G | |
| | | IPro | IPat | | Fluoxetin-Mepha
Dispersible 20 mg | 100 Comprimé(s) | 35.27 | 54.70 | 10% | | Comprimés dispersibles: Fluoxetinum 20 mg | Mepha Pharma AG | ● B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 2 mg | 30 Comprimé(s) | 2.81 | 12.30 | 10% | | Comprimés: Glimepiridum 2 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 2 mg | 120 Comprimé(s) | 9.16 | 26.40 | 10% | | Comprimés: Glimepiridum 2 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 3 mg | 30 Comprimé(s) | 3.90 | 13.50 | 10% | | Comprimés: Glimepiridum 3 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 3 mg | 120 Comprimé(s) | 13.39 | 31.00 | 10% | | Comprimés: Glimepiridum 3 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 4 mg | 30 Comprimé(s) | 4.79 | 14.45 | 10% | | Comprimés: Glimepiridum 4 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| L | | IPro | IPat | CM | Glimepiride Zentiva 4 mg | 120 Comprimé(s) | 16.14 | 33.95 | 10% | | Comprimés: Glimepiridum 4 mg | Helvepharm AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Emselex 7.5 mg - C | 14 Comprimé(s) | 10.20 | 27.50 | 10% | | Comprimés retards: Darifenacinum 7.5 mg | CPS Cito Pharma
Services GmbH | B / LS | FB | | G | |
| | | IPro | IPat | | Emselex 7.5 mg - C | 56 Comprimé(s) | 40.77 | 60.75 | 10% | | Comprimés retards: Darifenacinum 7.5 mg | CPS Cito Pharma
Services GmbH | B / LS | FB | | G | |
| | | IPro | IPat | | Emselex 15 mg - C | 14 Comprimé(s) | 10.20 | 27.50 | 10% | | Comprimés retards: Darifenacinum 15 mg | CPS Cito Pharma
Services GmbH | B / LS | FB | | G | |
| | | IPro | IPat | | Emselex 15 mg - C | 56 Comprimé(s) | 40.77 | 60.75 | 10% | | Comprimés retards: Darifenacinum 15 mg | CPS Cito Pharma
Services GmbH | B / LS | FB | | G | |
| | | IPro | IPat | | Fluimucil 600 mg | 12 Comprimé(s) | 6.41 | 9.05 | 10% | | Comprimés: Acetylcysteinum 600 mg | Zambon Svizzera SA | D / LS | FB | | G | |
| | | IPro | IPat | | Fluimucil 600 mg | 30 Comprimé(s) | 14.10 | 31.75 | 10% | | Comprimés: Acetylcysteinum 600 mg | Zambon Svizzera SA | B / LS | FB | | G | |
| L | | IPro | IPat | | Fluimucil 600 mg | 60 Comprimé(s) | 25.32 | 43.95 | 10% | | Comprimés: Acetylcysteinum 600 mg | Zambon Svizzera SA | B / LS | FB | | G | |
| | | IPro | IPat | | Redoxon orange 1g | 30 Comprimé(s) | DDP | DDP | N.O. | | comprimés effervescents: Acidum Ascorbicum 1 g | Bayer (Schweiz) AG | D | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | 4 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | 6 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | 12 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 7.5 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 7.5mg / 0.15ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 10 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 10mg / 0.2ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 15 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 15mg / 0.3ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 20 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 20mg / 0.4ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 25 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 25mg / 0.5ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 30 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 30mg / 0.6ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 12.5 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 12.5mg / 0.25ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 17.5 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 17.5mg / 0.35ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 22.5 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 22.5mg / 0.45ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Metoject 27.5 mg | 24 seringue(s) | DDP | DDP | N.O. | | Solution injectable: Methotrexatum 27.5mg / 0.55ml | Gebro Pharma AG | A | FB | | G | |
| | | IPro | IPat | | Lamisil Pedisan Once | 4 g | DDP | DDP | N.O. | | Solution filmogène: Terbinafinum 10 mg/g | Medius AG | D | FB | | G | |
